US2023061736A1PendingUtilityA1

Gpr119 agonists

66
Assignee: KALLYOPE INCPriority: Oct 7, 2019Filed: Jul 28, 2022Published: Mar 2, 2023
Est. expiryOct 7, 2039(~13.2 yrs left)· nominal 20-yr term from priority
A61P 3/00A61K 45/06A61K 31/506C07D 405/14C07D 401/04C07D 403/14C07H 15/26C07D 401/12C07D 401/14
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This disclosure is directed, at least in part, to GPR119 agonists useful for the treatment of conditions or disorders involving the gut-brain axis. In some embodiments, the GPR119 agonists are gut-restricted compounds. In some embodiments, the condition or disorder is a metabolic disorder, such as diabetes, obesity, nonalcoholic steatohepatitis (NASH), or a nutritional disorder such as short bowel syndrome.

Claims

exact text as granted — not AI-modified
1 . A compound of Formula (I): 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, 
         wherein: 
         K is 
       
       
         
           
           
               
               
           
         
         R 1  is hydrogen, —OH, C 1-8  alkyl, C 3-8  cycloalkyl, or 3- to 8-membered heterocycloalkyl, wherein the alkyl, cycloalkyl, and heterocycloalkyl are unsubstituted or substituted by 1-3 substituents independently selected from halogen, —OH, and —O(C 1-6  alkyl); 
         each R 2  and R 3  is independently hydrogen, C 1-6  alkyl, or C 1-6  fluoroalkyl; 
         or R 2  and R 3  on the same carbon atom are taken together to form ═O; 
         R 4  is hydrogen, C 1-8  alkyl, C 1-8  fluoroalkyl, C 2-8  alkenyl, C 2-8  alkynyl, C 3-8  cycloalkyl, C 5-8  cycloalkenyl, 4- to 8-membered heterocycloalkyl, —[(CH 2 ) r —Z] t —R 6 , —[(CHR d ) r —Z] t —R 6 , or —[(C(R d ) 2 ) r —Z] t —R 6 ; wherein each alkyl, fluoroalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, and 4- to 8-membered heterocycloalkyl is unsubstituted or substituted by 1-6 R c  groups; 
         R 5  is C 1-8  alkyl, C 1-8  fluoroalkyl, C 2-8  alkenyl, C 2-8  alkynyl, C 3-8  cycloalkyl, C 5-8  cycloalkenyl, 4- to 8-membered heterocycloalkyl, —[(CH 2 ) r —Z] t —R 6 , —[(CHR d ) r —Z] t —R 6 , or —[(C(R d ) 2 ) r —Z] t —R 6 ; wherein each alkyl, fluoroalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, and 4- to 8-membered heterocycloalkyl is substituted by 1-6 R c  groups; 
         each Z is independently —CH 2 O—, —CH 2 NR d —, —CH 2 N + (R d ) 2 —, —NH—C(═O)—NH—, —C(═O)NH—, —CH 2 S(═O) 2 —, or —CH 2 S(═O)—; 
         each r is independently 1-6; 
         each t is independently 1-6; 
         R 6  is hydrogen, C 1-8  alkyl, C 1-8  fluoroalkyl, C 2-8  alkenyl, C 2-8  alkynyl, C 3-8  cycloalkyl, C 5-8  cycloalkenyl, or 4- to 8-membered heterocycloalkyl, wherein the alkyl, fluoroalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, or 4- to 8-membered heterocycloalkyl is unsubstituted or substituted by 1-6 R c  groups; 
         or R 4  and R 5  are taken together with the nitrogen to which they are attached to form a 4- to 8-membered heterocycloalkyl, which is unsubstituted or substituted by 1-6 R c  groups; 
         R 7  is hydrogen, C 1-4  alkyl, or C 1-4  fluoroalkyl; 
         R 8  is C 1-8  alkyl, C 1-8  fluoroalkyl, C 2-8  alkenyl, C 2-8  alkynyl, C 3-8  cycloalkyl, C 5-8  cycloalkenyl, 4- to 8-membered heterocycloalkyl, —[(CH 2 ) r —Z] t —R 6 , —[(CHR d ) r —Z] t —R 6 , or —[(CR d   2 ) r —Z] t —R 6 ; wherein each alkyl, fluoroalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, and 4- to 8-membered heterocycloalkyl is substituted by 1-6 R e  groups; 
         or R 8  is —(C 1-8  alkyl)-NH—R 9 , —(C 1-8  alkyl)-C(═O)NH—R 9 , —(C 1-8  alkyl)-C(═O)—N(R 9 ) 2 , or —(C 1-8  alkyl)-NHC(═O)NH—R 9 ; wherein the alkyl is unsubstituted or substituted by 1-6 R c  groups; 
         each R 9  is independently C 1-8  alkyl, or C 1-8  fluoroalkyl which is substituted by 1-6 R c  groups; 
         or two R 9  are taken together with the nitrogen to which they are attached to form a 4- to 6-membered heterocycloalkyl, which is substituted by 1-6 R c  groups; 
         each R c  is independently —OH, —CH 2 OH, —CH 2 CH 2 OH, —NH 2 , —CH 2 NH 2 , —NH(R d ), —CH 2 NH(R d ), —N(R d ) 2 , —CH 2 N(R d ) 2 , —N(R d ) 3   + , —C(═O)OH, —CH 2 C(═O)OH, —CH 2 CH 2 C(═O)OH, —S(═O) 2 OH, —S(═O)OH, —S(═O) 2 NH 2 , —P(═O)(OH) 2 , —P(═O)(OH)(R d ), —P(═O)(OH)(H), P(═O)(OH)(OR d ), —B(OH) 2 , —B(OR d )(OH), —NHCONHS(═O) 2 (R d ), —N(R d )CONHS(═O) 2 (R d ), —NHCON(R d )S(═O) 2 (R d ), —C(═O)NHS(═O) 2 (R d ), —S(═O) 2 NHC(═O)R d , —NHC(═NH)NH 2 , —NHC(═NH)NHR d , —NHC(═NH)N(R d ) 2 , —N(R d )C(═NH)NH 2 , —N(R d )C(═NH)NH(R d ), —N(R d )C(═NH)N(R d ) 2 , —NHC(═N(R d ))NH 2 , —NHC(═N(R d ))NHR d , —NHC(═N(R d ))N(R d ) 2 , —N(R d )C(═N(R d ))NH 2 , —N(R d )C(═N(R d ))NHR d , —N(R d )C(═N(R d ))N(R d ) 2 , —NHC(═NH)NHC(═NH)NH 2 , —N(R d )C(═NH)NHC(═NH)NH 2 , 
       
       
         
           
           
               
               
           
         
          or a 4- to 6-membered heterocycle which is unsubstituted or substituted with 1, 2, 3, or 4 substituents selected from C 1-6  alkyl, —O—(C 1-6  alkyl), —OH, ═O and ═S; 
         each R d  is independently C 1-6  alkyl, C 1-6  fluoroalkyl, or C 3-6  cycloalkyl; 
         each R e  is independently —OH, —CH 2 OH, —CH 2 CH 2 OH, —N(R d ) 3   + , —C(═O)OH, —CH 2 C(═O)OH, —CH 2 CH 2 C(═O)OH, —S(═O) 2 OH, —S(═O)OH, —S(═O) 2 NH 2 , —P(═O)(OH) 2 , —P(═O)(OH)(R d ), —P(═O)(OH)(H), —P(═O)(OH)(OR d ), —B(OH) 2 , —B(OR d )(OH), —NHCONHS(═O) 2 (R d ), —N(R d )CONHS(═O) 2 (R d ), —NHCON(R d )S(═O) 2 (R d ), —C(═O)NHS(═O) 2 (R d ), —S(O) 2 NHC(O)R d , —NHC(═NH)NH 2 , —NHC(═NH)NHR d , —NHC(═NH)N(R d ) 2 , —N(R d )C(═NH)NH 2 , N(R d )C(═NH)NH(R d ), —N(R d )C(═NH)N(R d ) 2 , —NHC(═N(R d ))NH 2 , —NHC(═N(R d ))NR d , —NHC(═N(R d ))N(R d ) 2 , —N(R d )C(═N(R d ))NH 2 , —N(R d )C(═N(R d ))NHR d , —N(R d )C(═N(R d ))N(R d ) 2 , —NHC(═NH)NHC(═NH)NH 2 , N(R d )C(═NH)NHC(═NH)NH 2 , 
       
       
         
           
           
               
               
           
         
          or a 4- to 6-membered heterocycle which is unsubstituted or substituted with 1, 2, 3, or 4 substituents selected from C 1-6  alkyl, —O—(C 1-6  alkyl), —OH, ═O and ═S; 
         Ring A is phenyl or 5-6 membered monocyclic heteroaryl; 
         each R a  is independently halogen, —CN, C 1-6  alkyl, C 1-6  fluoroalkyl, or C 3-6  cycloalkyl; 
         X, when K is 
       
       
         
           
           
               
               
           
         
          is —O—, —NR N —, *—CH 2 O—, *—CH 2 NR N —, *—C(═O)O—, *—C(═O)NR N —, *—CH 2 C(═O)O—, *—CH 2 C(═O)NR N —, *—OC(═O)—, *—NR N C(═O)—, *—CH 2 OC(═O)—, or *—CH 2 NR N C(═O)—, where * represents the attachment point to Ring A; 
         R N  is hydrogen or C 1-4  alkyl; 
         or X, when K is 
       
       
         
           
           
               
               
           
         
          is —O—, —NR N —, *—CH 2 O—, *—CH 2 NR N —, *—C(═O)O—, *—C(═O)NR N —, *—CH 2 C(═O)O—, *—CH 2 C(═O)NR N —, *—OC(═O)—, *—CH 2 OC(═O)—, or *—CH 2 NR N C(═O)—, where * represents the attachment point to Ring A; 
         R N  is hydrogen or C 1-4  alkyl; 
         each R 11  is independently hydrogen, fluorine, —OH, C 1-6  alkyl, or C 1-6  alkoxy; 
         each R 12  is independently hydrogen, fluorine, or C 1-6  alkyl; 
         or, when K is 
       
       
         
           
           
               
               
           
         
          two R 11  are taken together with the intervening atoms to which they are attached to form a C 3-6  cycloalkyl; 
         or, when K is 
       
       
         
           
           
               
               
           
         
          two R 11  are taken together with the intervening atoms to which they are attached to form a C 4-6  cycloalkyl; 
         R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , and R 20  are each independently hydrogen, C 1-6  alkyl, C 1-6  alkoxy, or C 1-6  fluoroalkyl; 
         or R 13  and R 17  or R 13  and R 19  or R 15  and R 19  are taken together with the intervening atoms to which they are attached to form a ring; 
         R 21  is hydrogen, C 1-6  alkyl, or C 1-6  fluoroalkyl; 
         or R 21  and one R 11  are taken together with the intervening atoms to which they are attached to form a C 3-6  cycloalkyl; 
         W is phenyl or 5-6 membered monocyclic heteroaryl, wherein the phenyl or heteroaryl is unsubstituted or substituted with 1, 2, or 3 substituents selected from R b ; 
         each R b  is independently halogen, —OH, —CN, —C(O)OH, —C(O)O(C 1-6  alkyl), C 1-6  alkyl, C 1-6  alkoxy, C 3-6  cycloalkyl, phenyl, or 5- to 6-membered heteroaryl; wherein each alkyl, alkoxy, and cycloalkyl is unsubstituted or substituted with 1, 2, or 3 substituents selected from halogen, —OH, C 1-6  alkyl, and C 1-6  alkoxy; 
         or W is —C(═O)O—R 22 ; 
         R 22  is C 1-6  alkyl, C 3-6  cycloalkyl, or 3- to 6-membered heterocycloalkyl, wherein the alkyl, cycloalkyl, and heterocycloalkyl are unsubstituted or substituted by 1-3 substituents independently selected from fluorine, —OH, C 1-6  alkyl, C 1-6  haloalkyl or C 3-6  cycloalkyl; 
         m is 1-4; 
         n is 0-4; 
         p is 1 or 2; 
         q is 1 or 2; and 
         s is 1 or 2. 
       
     
     
         2 . The compound of  claim 1 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 X is —O—, *—CH 2 O—, *—C(═O)O—, or *—CH 2 C(═O)O—, where * represents the attachment point to Ring A;   each R 11  is independently hydrogen, fluorine, —OH, C 1-6  alkyl, or C 1-6  alkoxy;   or, when K is   
       
         
           
           
               
               
           
         
          two R 11  on adjacent carbon atoms are taken together with the intervening atoms to which they are attached to form a cyclopropyl; 
         R 21  is hydrogen or C 1-6  alkyl; and 
         R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , and R 20  are each independently hydrogen or C 1-6  alkyl. 
       
     
     
         3 . The compound of  claim 1 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 X is —O—;   each R 11  is hydrogen;   each R 12  is hydrogen;   R 21  is hydrogen; and   R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , and R 20  are each hydrogen.   
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . The compound of  claim 1 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein the compound has the structure of Formula (Ia), or a pharmaceutically acceptable salt, or solvate thereof: 
       
         
           
           
               
               
           
         
       
     
     
         7 . (canceled) 
     
     
         8 . The compound of  claim 6 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 W is 6-membered monocyclic heteroaryl, wherein the heteroaryl is unsubstituted or substituted with 1 or 2 substituents selected from R b ; and   each R b  is independently halogen, —C(O)OH, —C(O)O(C 1-6  alkyl), C 1-6  alkyl, C 1-6  alkoxy, or C 3-6  cycloalkyl; wherein each alkyl, alkoxy, and cycloalkyl is unsubstituted or substituted with 1, 2, or 3 substituents selected from halogen, —OH, C 1-6  alkyl, and C 1-6  alkoxy.   
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . The compound of  claim 6 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 K is   
       
         
           
           
               
               
           
         
       
     
     
         12 . The compound of  claim 11 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 R 1  is hydrogen, —OH, or C 1-8  alkyl, wherein the alkyl is unsubstituted or substituted by —OH or —O(C 1-6  alkyl);   each R 2  and R 3  is hydrogen;   or R 2  and R 3  on the same carbon atom are taken together to form ═O;   R 4  is hydrogen or C 1-8  alkyl;   R 5  is C 1-8  alkyl, C 2-8  alkenyl, C 2-8  alkynyl, C 3-8  cycloalkyl, C 5-8  cycloalkenyl, 4- to 8-membered heterocycloalkyl, —[(CH 2 ) r —Z] t —R 6 , —[(CR d ) r —Z] t —R 6 , or —[(C(R d ) 2 ) r —Z] t —R 6 ;   wherein each alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, and 4- to 8-membered heterocycloalkyl is substituted by 1-6 R c  groups;   p is 1; and   q is 1.   
     
     
         13 . (canceled) 
     
     
         14 . (canceled) 
     
     
         15 . The compound of  claim 11 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 R 4  is hydrogen or C 1-4  alkyl;   R 5  is C 1-8  alkyl, —[(CH 2 ) r —Z] t —R 6 , —[(CHR d ) r —Z] t —R 6 , or —[(C(R d ) 2 ) r —Z] t —R 6 ; wherein the alkyl is substituted by 1-6 R c  groups;   each Z is independently —CH 2 O—, —CH 2 NR d —, or —NH—C(═O)—NH—;   r is 1-3;   t is 1-3;   R 6  is hydrogen or C 1-8  alkyl, wherein the alkyl is substituted by 1-6 R c  groups; and   each R c  is independently —OH, —CH 2 OH, —NH 2 , —N(R d ) 3   + , —C(═O)OH, or   
       
         
           
           
               
               
           
         
       
     
     
         16 . (canceled) 
     
     
         17 . The compound of  claim 11 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 R 5  is C 1-8  alkyl which is substituted by 1-6 R c  groups; and   each R c  is independently —OH, —CH 2 OH, —N(R d ) 3   + , —C(═O)OH, or   
       
         
           
           
               
               
           
         
       
     
     
         18 . The compound of  claim 11 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 R 4  is hydrogen; and   R 5  is C 1-8  alkyl which is substituted by 1-6 —OH groups.   
     
     
         19 . The compound of  claim 11 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 R 4  and R 5  are taken together with the nitrogen to which they are attached to form a 4- to 8-membered heterocycloalkyl, which is unsubstituted or substituted by 1-6 R c  groups.   
     
     
         20 . The compound of  claim 11 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 R 4  and R 5  are taken together with the nitrogen to which they are attached to form a 5- or 6-membered heterocycloalkyl, which is unsubstituted or substituted by 1-3-OH groups.   
     
     
         21 . The compound of  claim 6 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 K is   
       
         
           
           
               
               
           
         
          wherein 
         R 7  is hydrogen or C 1-4  alkyl; 
         R 8  is C 1-8  alkyl, C 3-8  cycloalkyl, —[(CH 2 ) r —Z] t —R 6 , —[(CHR d ) r —Z] t —R 6 , or —[(CR d   2 ) r —Z] t —R 6 ; 
         wherein the alkyl or cycloalkyl is substituted by 1-6 R e  groups 
         each Z is independently —CH 2 O—, —CH 2 NR d —, —CH 2 N + (R d ) 2 —, or —NH—C(═O)—NH—; 
         R 6  is hydrogen, C 1-8  alkyl, C 3-8  cycloalkyl, or 4- to 8-membered heterocycloalkyl, wherein the alkyl, cycloalkyl, or 4- to 8-membered heterocycloalkyl is unsubstituted or substituted by 1-6 R c  groups; 
         or R 8  is —(C 1-8  alkyl)-NH—R 9 , —(C 1-8  alkyl)-C(═O)NH—R 9 , —(C 1-8  alkyl)-C(═O)—N(R 9 ) 2 , or —(C 1-8  alkyl)-NHC(═O)NH—R 9 ; wherein the alkyl is unsubstituted or substituted by 1-6 R c  groups; 
         each R 9  is independently C 1-8  alkyl which is substituted by 1-6 R c  groups; 
         or two R 9  are taken together with the nitrogen to which they are attached to form a 4- to 6-membered heterocycloalkyl, which is substituted by 1-6 R c  groups; 
         each R c  is independently —OH, —CH 2 OH, —NH 2 , —N(R d ) 3   + , —C(═O)OH, —S(═O) 2 OH, —S(═O) 2 NH 2 , —P(═O)(OH) 2 , —P(═O)(OH)(R d ), —P(═O)(OH)(OR d ), 
       
       
         
           
           
               
               
           
         
         each R d  is independently C 1-6  alkyl; and 
         each R e  is independently —OH, —CH 2 OH, —N(R d ) 3   + , —C(═O)OH, —S(═O) 2 OH, —S(═O) 2 NH 2 , —P(═O)(OH) 2 , —P(═O)(OH)(R d ), —P(═O)(OH)(OR d ), 
       
       
         
           
           
               
               
           
         
       
     
     
         22 . (canceled) 
     
     
         23 . The compound of  claim 21 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, wherein:
 each R c  is independently —OH, —CH 2 OH, or —N(R d ) 3   + ; and   R 8  is C 1-8  alkyl; wherein the alkyl is substituted by 1-6 R e  groups; wherein   each R e  is independently —OH, —CH 2 OH, —N(R d ) 3   + , —S(═O) 2 OH, —S(═O) 2 NH 2 , or   
       
         
           
           
               
               
           
         
         or R 8  is —(C 1-8  alkyl)-NH—R 9 , —(C 1-8  alkyl)-C(═O)NH—R 9 , —(C 1-8  alkyl)-C(═O)—N(R 9 ) 2 , or —(C 1-8  alkyl)-NHC(═O)NH—R 9 ; wherein the alkyl is unsubstituted. 
       
     
     
         24 . (canceled) 
     
     
         25 . (canceled) 
     
     
         26 . (canceled) 
     
     
         27 . (canceled) 
     
     
         28 . (canceled) 
     
     
         29 . (canceled) 
     
     
         30 . (canceled) 
     
     
         31 . (canceled) 
     
     
         32 . The compound of  claim 1 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, selected from:
 2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-N-[5-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]pentyl]acetamide;   5-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]pentyl-triethyl-ammonium;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-N-[5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentyl]acetamide;   5-[[2-[2,6-difluoro-4-[3-[1-(5-propylpyrimidin-2-yl)-4-piperidyl]propoxy]phenyl]acetyl]amino]pentyl-triethyl-ammonium;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]acetamide;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]acetamide;   2-[4-[3-[1-(5-ethylpyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]acetamide;   2-[2,6-difluoro-4-[3-[1-(5-propylpyrimidin-2-yl)-4-piperidyl]propoxy]phenyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]acetamide;   1-[3,3-bis(hydroxymethyl)azetidin-1-yl]-2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]ethanone;   2-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]ethanesulfonic acid;   3-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]propane-1-sulfonic acid;   4-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]butane-1-sulfonic acid;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-N-(3-sulfamoylpropyl)acetamide;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-N-(4-sulfamoylbutyl)acetamide;   3-[[2-[4-[3-[1-(5-ethylpyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]propyl-trimethyl-ammonium;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-N-[2-[rac-(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyethyl]acetamide;   6-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]-N-[2-hydroxy-1-(hydroxymethyl)ethyl]hexanamide;   6-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]hexanamide;   3-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]-N-[2-hydroxy-1-(hydroxymethyl)ethyl]propenamide;   3-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]propenamide;   4-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]-N-[2-hydroxy-1-(hydroxymethyl)ethyl]butanamide;   4-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]butanamide;   5-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]-N-[2-hydroxy-1-(hydroxymethyl)ethyl]pentanamide;   5-[[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]amino]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]pentanamide;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-N-[6-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-6-oxo-hexyl]acetamide;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]acetyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]azetidine-3-carboxamide;   1-[2-[2-fluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]acetyl]-N-[2-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]carbamoylamino]ethyl]azetidine-3-carboxamide;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[2-hydroxy-1-(hydroxymethyl)ethyl]azetidine-3-carboxamide;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]azetidine-3-carboxamide;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[2,3-dihydroxy-2-(hydroxymethyl)propyl]azetidine-3-carboxamide;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[2-[rac-(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyethyl]azetidine-3-carboxamide;   2-[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidin-3-yl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]acetamide;   2-[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidin-3-yl]-N-[2,3-dihydroxy-2-(hydroxymethyl)propyl]acetamide;   2-[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]acetyl]azetidin-3-yl]-N-[2,3-dihydroxy-2-(hydroxymethyl)propyl]acetamide;   3-[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidin-3-yl]-N-[2,3-dihydroxy-2-(hydroxymethyl)propyl]propenamide;   3-[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]acetyl]azetidin-3-yl]-N-[2,3-dihydroxy-2-(hydroxymethyl)propyl]propenamide;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]azetidine-3-carboxamide;   2-[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidin-3-yl]-N-[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]acetamide;   1-[2-[2-fluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]acetyl]-N-[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]azetidine-3-carboxamide;   3-[[1-[2-[2,6-difluoro-4-[3-[1-(5-propylpyrimidin-2-yl)-4-piperidyl]propoxy]phenyl]acetyl]azetidine-3-carbonyl]amino]propyl-trimethyl-ammonium formate;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[2,3-dihydroxy-2-(hydroxymethyl)propyl]piperidine-4-carboxamide;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[[2,3-dihydroxy-2-(hydroxymethyl)propyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[[3-hydroxy-2-(hydroxymethyl)propyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[rac-(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[rac-(3R,4R)-3,4-dihydroxypyrrolidin-1-yl]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[rac-(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[[rac-(1R,2S,3R,4S)-2,3,4-trihydroxycyclopentyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[rac-(3R,5S)-3,4,5-trihydroxy-1-piperidyl]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[2-[2-(2-hydroxyethoxy)ethoxy]ethylamino]methyl]azetidin-1-yl]ethanone;   1-[3-[[2-[2-(2-aminoethoxy)ethoxy]ethylamino]methyl]azetidin-1-yl]-2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[4-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]butoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-(4-(4-(1-(5-chloropyrimidin-2-yl)piperidin-4-yl)butoxy)-2,6-difluorophenyl)-1-(3-((((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)amino)methyl)azetidin-1-yl)ethan-1-one;   2-(4-(3-(1-(5-chloropyrimidin-2-yl)piperidin-4-yl)propoxy)-2-fluorophenyl)-1-(3-(2-((1,3-dihydroxypropan-2-yl)amino)ethyl)azetidin-1-yl)ethan-1-one;   2-(4-(3-(1-(5-chloropyrimidin-2-yl)piperidin-4-yl)propoxy)-2-fluorophenyl)-1-(3-(2-((3-hydroxy-2-(hydroxymethyl)propyl)amino)ethyl)azetidin-1-yl)ethan-1-one;   2-(4-(3-(1-(5-chloropyrimidin-2-yl)piperidin-4-yl)propoxy)-2-fluorophenyl)-1-(3-(2-((2,3-dihydroxy-2-(hydroxymethyl)propyl)amino)ethyl)azetidin-1-yl)ethan-1-one;   2-(4-(3-(1-(5-chloropyrimidin-2-yl)piperidin-4-yl)propoxy)-2-fluorophenyl)-1-(3-(2-((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)ethyl)azetidin-1-yl)ethan-1-one;   1-(2-((2-(1-(2-(4-(3-(1-(5-chloropyrimidin-2-yl)piperidin-4-yl)propoxy)-2-fluorophenyl)acetyl)azetidin-3-yl)ethyl)amino)ethyl)-3-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)urea;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[2-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]ethyl]azetidin-1-yl]ethanone;   2-(4-(3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propoxy)-2-fluorophenyl)-1-(3-(((3-hydroxy-2-(hydroxymethyl)propyl)amino)methyl)azetidin-1-yl)ethan-1-one;   1-(3-(((2,3-dihydroxy-2-(hydroxymethyl)propyl)amino)methyl)azetidin-1-yl)-2-(4-(3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propoxy)-2-fluorophenyl)ethan-1-one;   1-(3-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methyl)azetidin-1-yl)-2-(4-(3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propoxy)-2-fluorophenyl)ethan-1-one;   1-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-3-(2-(((1-(2-(4-(3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propoxy)-2-fluorophenyl)acetyl)azetidin-3-yl)methyl)amino)ethyl)urea;   (2S,3R,4S,5S)-6-[[1-[2-[4-[3-[1-(5-ethylpyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidin-3-yl]methylamino]-2,3,4,5-tetrahydroxy-hexanoic acid;   1-(3-(((2,3-dihydroxy-2-(hydroxymethyl)propyl)amino)methyl)azetidin-1-yl)-2-(4-(3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propoxy)-2,6-difluorophenyl)ethan-1-one;   1-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-3-(2-(((1-(2-(4-(3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propoxy)-2,6-difluorophenyl)acetyl)azetidin-3-yl)methyl)amino)ethyl)urea;   2-(4-(3-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)propoxy)-2,6-difluorophenyl)-1-(3-((((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)amino)methyl)azetidin-1-yl)ethan-1-one;   2-(2-fluoro-4-(3-(1-(5-propylpyrimidin-2-yl)piperidin-4-yl)propoxy)phenyl)-1-(3-(((3-hydroxy-2-(hydroxymethyl)propyl)amino)methyl)azetidin-1-yl)ethan-1-one;   1-(3-(((2,3-dihydroxy-2-(hydroxymethyl)propyl)amino)methyl)azetidin-1-yl)-2-(2-fluoro-4-(3-(1-(5-propylpyrimidin-2-yl)piperidin-4-yl)propoxy)phenyl)ethan-1-one;   1-(3-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methyl)azetidin-1-yl)-2-(2-fluoro-4-(3-(1-(5-propylpyrimidin-2-yl)piperidin-4-yl)propoxy)phenyl)ethan-1-one;   1-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-3-(2-(((1-(2-(2-fluoro-4-(3-(1-(5-propylpyrimidin-2-yl)piperidin-4-yl)propoxy)phenyl)acetyl)azetidin-3-yl)methyl)amino)ethyl)urea;   2-(2-fluoro-4-(3-(1-(5-propylpyrimidin-2-yl)piperidin-4-yl)propoxy)phenyl)-1-(3-((((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)amino)methyl)azetidin-1-yl)ethan-1-one;   2-(2,6-difluoro-4-(3-(1-(5-propylpyrimidin-2-yl)piperidin-4-yl)propoxy)phenyl)-1-(3-(((2,3-dihydroxy-2-(hydroxymethyl)propyl)amino)methyl)azetidin-1-yl)ethan-1-one;   2-(2,6-difluoro-4-(3-(1-(5-propylpyrimidin-2-yl)piperidin-4-yl)propoxy)phenyl)-1-(3-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methyl)azetidin-1-yl)ethan-1-one;   1-(2-(((1-(2-(2,6-difluoro-4-(3-(1-(5-propylpyrimidin-2-yl)piperidin-4-yl)propoxy)phenyl)acetyl)azetidin-3-yl)methyl)amino)ethyl)-3-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)urea;   2-(2,6-difluoro-4-(3-(1-(5-propylpyrimidin-2-yl)piperidin-4-yl)propoxy)phenyl)-1-(3-((((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)amino)methyl)azetidin-1-yl)ethan-1-one;   2-[2-fluoro-4-[3-[1-(5-methoxypyrimidin-2-yl)-4-piperidyl]propoxy]phenyl]-1-[3-[[[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   1-[2-[[1-[2-[2-fluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]acetyl]azetidin-3-yl]methylamino]ethyl]-3-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]urea;   (3R,5R)-7-[[1-[2-[2-fluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]acetyl]azetidin-3-yl]methylamino]-3,5-dihydroxy-heptanoic acid;   2-[2-fluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[2-fluoro-4-[4-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]butoxy]phenyl]-1-[3-[[[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[2,6-difluoro-4-[4-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]butoxy]phenyl]-1-[3-[[[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[2-[(1S,2R)-2-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]cyclopropyl]ethoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   methyl 2-[4-[3-[3-fluoro-4-[2-oxo-2-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]propyl]-1-piperidyl]pyrimidine-5-carboxylate;   2-[4-[2-[1-(5-ethylpyrimidin-2-yl)-4-piperidyl]ethoxymethyl]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]cyclobutyl]ethanone;   2-[4-[2-[1-(5-ethylpyrimidin-2-yl)-4-piperidyl]ethoxymethyl]-3-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]cyclobutyl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxymethyl]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]ethyl 3-fluoro-4-[2-oxo-2-[3-[[[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]benzoate;   2-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]ethyl 2-[3-fluoro-4-[2-oxo-2-[3-[[[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenyl]acetate;   2-[2-fluoro-4-[3-[1-[5-(hydroxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[2,6-difluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   [rac-(1R,2R)-2-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]cyclopropyl]methyl 3-fluoro-4-[2-oxo-2-[3-[[[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]benzoate;   2-[2-fluoro-4-[[(1R,2R)-2-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]cyclopropyl]methoxymethyl]phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[2-fluoro-4-[2-[rac-(1S,2R)-2-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]cyclopropyl]ethoxy]phenyl]-1-[3-[[[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3S)-3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3S)-3-[[[2,3-dihydroxy-2-(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3R)-3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3R)-3-[[[2,3-dihydroxy-2-(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   (3R)-1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]pyrrolidine-3-carboxamide;   (3S)-1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]pyrrolidine-3-carboxamide;   2-[4-[2-[7-(5-chloropyrimidin-2-yl)-7-azaspiro[3.5]nonan-2-yl]ethoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[7-(5-chloropyrimidin-2-yl)-7-azaspiro[3.5]nonan-2-yl]propoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[4-[7-(5-chloropyrimidin-2-yl)-7-azaspiro[3.5]nonan-2-yl]butoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[[7-(5-chloropyrimidin-2-yl)-7-azaspiro[3.5]nonan-2-yl]methoxymethyl]-2-fluoro-phenyl]-1-[3-[[[2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   N-[2,3-dihydroxy-2-(hydroxymethyl)propyl]-2-[1-[2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidin-3-yl]acetamide;   2-[4-[4-[1-(5-chloropyrimidin-2-yl)-4-methyl-4-piperidyl]butoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[2-[6-(5-chloropyrimidin-2-yl)-6-azaspiro[2.5]octan-2-yl]ethoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[[6-(5-chloropyrimidin-2-yl)-6-azaspiro[2.5]octan-2-yl]methoxymethyl]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   isopropyl 4-[3-[3-fluoro-4-[2-oxo-2-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]propyl]piperidine-1-carboxylate;   2-[4-[3-[(1R,5S)-3-(5-chloropyrimidin-2-yl)-3-azabicyclo[3.1.0]hexan-6-yl]propoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[2-[7-(5-chloropyrimidin-2-yl)-7-azaspiro[3.5]nonan-2-yl]ethoxy]-2,6-difluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[7-(5-chloropyrimidin-2-yl)-7-azaspiro[3.5]nonan-2-yl]propoxy]-2,6-difluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   isopropyl 2-[3-[3-fluoro-4-[2-oxo-2-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]propyl]-7-azaspiro[3.5]nonane-7-carboxylate;   isopropyl 2-[2-[3-fluoro-4-[2-oxo-2-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]ethyl]-7-azaspiro[3.5]nonane-7-carboxylate;   (1-methylcyclopropyl) 4-[3-[3-fluoro-4-[2-oxo-2-[3-[[[rac-(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]propyl]piperidine-1-carboxylate;   2-[4-[[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]cyclobutyl]methoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-(methoxymethyl)-3-[[[r(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]-3-(methoxymethyl)pyrrolidin-1-yl]ethanone;   2-[4-[2-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]cyclobutyl]ethoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[2-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]cyclobutyl]ethoxy]-2,6-difluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   [3-(trifluoromethyl)oxetan-3-yl] 4-[3-[3-fluoro-4-[2-oxo-2-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]propyl]piperidine-1-carboxylate;   [3-(trifluoromethyl)oxetan-3-yl] 4-[3-[3,5-difluoro-4-[2-oxo-2-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]propyl]piperidine-1-carboxylate;   (3S)-1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]pyrrolidine-3-carboxamide;   (3S)-1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]acetyl]-N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]pyrrolidine-3-carboxamide;   (3S)-1-[2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]pyrrolidine-3-carboxamide;   (3S)-1-[2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]acetyl]-N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]pyrrolidine-3-carboxamide;   (3S)-1-[2-[2,6-difluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]acetyl]-N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]pyrrolidine-3-carboxamide;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[(3S)-3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3S)-3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[(3S)-3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[2,6-difluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]-1-[(3S)-3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]pyrrolidin-1-yl]ethanone;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-3-(methoxymethyl)-N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]pyrrolidine-3-carboxamide;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-N-[3-hydroxy-2,2-bis(hydroxymethyl)propyl]-3-(methoxymethyl)pyrrolidine-3-carboxamide;   2-[4-[2-[7-(5-chloropyrimidin-2-yl)-7-azaspiro[3.5]nonan-3-yl]ethoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[2-[7-(5-chloropyrimidin-2-yl)-7-azaspiro[3.5]nonan-3-yl]ethoxy]-2,6-difluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   isopropyl 3-[2-[3-fluoro-4-[2-oxo-2-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]ethyl]-7-azaspiro[3.5]nonane-7-carboxylate;   isopropyl 3-[2-[3,5-difluoro-4-[2-oxo-2-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]ethyl]-7-azaspiro[3.5]nonane-7-carboxylate;   2-[4-[3-[6-(5-chloropyrimidin-2-yl)-6-azaspiro[2.5]octan-2-yl]propoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[6-(5-chloropyrimidin-2-yl)-6-azaspiro[2.5]octan-2-yl]propoxy]-2,6-difluoro-phenyl]-1-[3-[[[2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[7-(5-chloropyrimidin-2-yl)-7-azaspiro[3.5]nonan-3-yl]propoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   isopropyl 2-[3-[3-fluoro-4-[2-oxo-2-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]propyl]-6-azaspiro[2.5]octane-6-carboxylate;   isopropyl 2-[3-[3,5-difluoro-4-[2-oxo-2-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethyl]phenoxy]propyl]-6-azaspiro[2.5]octane-6-carboxylate;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3S)-3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3S)-3-[[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[(3S)-3-[[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[(3S)-3-[[[2,3-dihydroxy-2-(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[(3S)-3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3S)-3-[[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3S)-3-[[[2,3-dihydroxy-2-(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3S)-3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[(3S)-3-[[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[(3S)-3-[[[2,3-dihydroxy-2-(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[(3S)-3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[2,6-difluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]-1-[(3S)-3-[[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[2,6-difluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]-1-[(3S)-3-[[[2,3-dihydroxy-2-(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[2,6-difluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]-1-[(3S)-3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[2-fluoro-4-[2-[(1S,2R)-2-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]cyclopropyl]ethoxy]phenyl]-1-[(3S)-3-[[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[2-fluoro-4-[2-[(1S,2R)-2-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]cyclopropyl]ethoxy]phenyl]-1-[(3S)-3-[[[2,3-dihydroxy-2-(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[2-fluoro-4-[2-[(1S,2R)-2-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]cyclopropyl]ethoxy]phenyl]-1-[(3S)-3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[2-[[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]amino]ethyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-[[[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[(3R)-3-[[[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[5-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-pyridyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[5-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-3-fluoro-2-pyridyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidine-3-carbonyl]amino]ethanesulfonic acid;   3-[[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidine-3-carbonyl]amino]propane-1-sulfonic acid;   4-[[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidine-3-carbonyl]amino]butane-1-sulfonic acid;   5-[[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidine-3-carbonyl]amino]pentane-1-sulfonic acid;   6-[[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidine-3-carbonyl]amino]hexane-1-sulfonic acid;   2-[[2-[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidin-3-yl]acetyl]amino]ethanesulfonic acid;   3-[[2-[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidin-3-yl]acetyl]amino]propane-1-sulfonic acid;   4-[[2-[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]azetidin-3-yl]acetyl]amino]butane-1-sulfonic acid;   2-[6-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-3-pyridyl]-1-[3-[[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-hydroxy-3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-3-hydroxy-N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]pyrrolidine-3-carboxamide;   1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-3-hydroxy-N-[3-hydroxy-2,2-bis(hydroxymethyl)propyl]pyrrolidine-3-carboxamide;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[4-hydroxy-4-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]-1-piperidyl]ethanone;   2-[1-[2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]acetyl]-3-hydroxy-azetidin-3-yl]-N-[3-hydroxy-2,2-bis(hydroxymethyl)propyl]acetamide;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-hydroxy-3-[[[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]amino]methyl]azetidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[3-hydroxy-3-[[[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2-fluoro-phenyl]-1-[4-hydroxy-4-[[[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]amino]methyl]-1-piperidyl]ethanone;   2-[4-[3-[1-(5-chloropyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[3-hydroxy-3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   2-[4-[3-[1-(5-ethoxypyrimidin-2-yl)-4-piperidyl]propoxy]-2,6-difluoro-phenyl]-1-[3-hydroxy-3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone; and   2-[2,6-difluoro-4-[3-[1-[5-(methoxymethyl)pyrimidin-2-yl]-4-piperidyl]propoxy]phenyl]-1-[3-hydroxy-3-[[[3-hydroxy-2,2-bis(hydroxymethyl)propyl]amino]methyl]pyrrolidin-1-yl]ethanone;   or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof.   
     
     
         33 . A pharmaceutical composition comprising a compound of  claim 1 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof, and at least one pharmaceutically acceptable excipient. 
     
     
         34 . A method of treating a condition or disorder involving the gut-brain axis in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a compound of  claim 1 , or a pharmaceutically acceptable salt, solvate, stereoisomer, or prodrug thereof; wherein the condition or disorder is associated with GPR119 activity. 
     
     
         35 . (canceled) 
     
     
         36 . The method of  claim 34 , wherein the condition or disorder is a metabolic disorder or a nutritional disorder. 
     
     
         37 . The method of  claim 36 , wherein the condition or disorder is type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, nonalcoholic steatohepatitis, hypertension, short bowel syndrome, intestinal failure, intestinal insufficiency, chemotherapy-induced enteritis, or radiation-induced enteritis. 
     
     
         38 . (canceled) 
     
     
         39 . (canceled) 
     
     
         40 . (canceled) 
     
     
         41 . (canceled) 
     
     
         42 . (canceled) 
     
     
         43 . The method of  claim 34 , further comprising administering one or more additional therapeutic agents to the subject: wherein the one or more additional therapeutic agents are selected from a TGR5 agonist, a GPR40 agonist, an SSTR5 antagonist, an SSTR5 inverse agonist, a CCK1 agonist, a PDE4 inhibitor, a DPP-4 inhibitor, a GLP-1 receptor agonist, metformin, or a combination thereof. 
     
     
         44 . (canceled) 
     
     
         45 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.